Results 121 to 130 of about 124,671 (340)
ON THE TREATMENT OF PULMONARY TUBERCULOSIS BY THE PROLONGED INHALATION OF ANTISEPTIC AND SEDATIVE VAPOURS. [PDF]
S.N Bruce
openalex +1 more source
Sleep Matters: Exploring the Link Between Sleep Disturbances and Fatigue in Rheumatoid Arthritis
Objective Fatigue is a prevalent and debilitating symptom for patients with rheumatoid arthritis (RA). Although patients and rheumatologists often attribute fatigue to inflammation, other factors such as sleep disturbances are frequently overlooked. This study aims to explore the relationship between subjective (self‐reported) and objective (actigraphy
Natalia V. Chalupczak+12 more
wiley +1 more source
Objectives Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centred care and informing local service pathways and care guidelines or standards.
Sonia Ranelli+8 more
wiley +1 more source
Chronic Opioids in Gout: A Matched Cohort Study from the Veteran's Health Administration
Objective Though used frequently to treat flare, risk of chronic opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed chronic opioids over time.
Lindsay N. Helget+7 more
wiley +1 more source
Correlation between Brain Catecholamine and Sedative Action of Reserpine [PDF]
MASAMI MATSUOKA+2 more
openalex +1 more source
Objective This study aimed to determine if program format (in‐person, virtual, hybrid) results in differences in three‐month outcomes of pain, function, quality of life, self‐efficacy and chair stands in a hip/knee osteoarthritis management program. Methods A secondary analysis of the GLA:DTM Canada database was completed.
Jill Van Damme+7 more
wiley +1 more source
PHARMACOLOGICAL PROPERTIES OF THALIDOMIDE (α‐PHTHALIMIDO GLUTARIMIDE), A NEW SEDATIVE HYPNOTIC DRUG [PDF]
G. Fred Somers
openalex +1 more source
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen+4 more
wiley +1 more source